Three-percent sucrose acts as a thermostabilizer for cell-adapted foot-and-mouth disease virus without any negative effect on viral growth

被引:4
作者
Hwang, J. -H. [1 ]
Moon, Y. [1 ]
Lee, G. [1 ]
Kim, M. -Y. [1 ]
Lee, K. -N. [1 ]
Park, J. -H. [1 ]
Lee, M. [1 ]
Kim, B. [1 ]
Kim, S. -M. [1 ]
机构
[1] Anim & Plant Quarantine Agcy, Ctr Foot & Mouth Dis Vaccine Res, 177 Hyeoksin 8 Ro, Gimcheon City, Gyeongsangbuk D, South Korea
关键词
cell-adapted virus; foot-and-mouth disease virus; stabilizer; thermostability; vaccine; THERMAL-STABILITY; STABILIZATION; CULTURE; VACCINE; BINDING; LYOPHILIZATION; EXPRESSION; EXCLUSION; STORAGE; RSV;
D O I
10.1111/jam.14565
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Aims As cell-adapted foot-and-mouth disease virus (FMDV) with H56R mutation in VP3 has reduced thermostability, this study aimed to investigate the effect of thermostabilizers on cell-adapted FMDV for vaccine production. Methods and Results We examined the effect of 3% sucrose, 10% (or 25%) glycerol or 10% FBS on cell-adapted FMDV O/SKR/JC/2014, containing H56R mutation in VP3, as vaccine seed virus at -80, 4, 25 or 37 degrees C for 2, 4 or 7 days. The stabilizing effect of 3% sucrose on O/SKR/JC/2014 was observed at 25, 37 degrees C, and after repeated freeze-thaw cycles. Additionally, we tested the effect of 3% sucrose on the growth of FMDV or cells and did not observe any decrease in either viral growth or cell viability. Conclusions Our study showed the protective effect of 3% sucrose on FMDV infectivity at various temperatures; this virus stock in 3% sucrose could be used for infecting cells without the removal of sucrose. Significance and Impact of the Study We suggest that 3% sucrose-containing medium could be beneficial for the stable storage and transport of cell-adapted FMDV.
引用
收藏
页码:1524 / 1531
页数:8
相关论文
共 43 条
  • [1] Long-Term Thermostabilization of Live Poxviral and Adenoviral Vaccine Vectors at Supraphysiological Temperatures in Carbohydrate Glass
    Alcock, Robert
    Cottingham, Matthew G.
    Rollier, Christine S.
    Furze, Julie
    De Costa, Samodh D.
    Hanlon, Marian
    Spencer, Alexandra J.
    Honeycutt, Jared D.
    Wyllie, David H.
    Gilbert, Sarah C.
    Bregu, Migena
    Hill, Adrian V. S.
    [J]. SCIENCE TRANSLATIONAL MEDICINE, 2010, 2 (19) : 19ra12
  • [2] The pathogenesis and diagnosis of foot-and-mouth disease
    Alexandersen, S
    Zhang, Z
    Donaldson, AI
    Garland, AJM
    [J]. JOURNAL OF COMPARATIVE PATHOLOGY, 2003, 129 (01) : 1 - 36
  • [3] IMMUNOGENICITY OF FOOT-AND-MOUTH-DISEASE VIRUS GROWN IN BHK-21 SUSPENSION CELLS - CORRELATION WITH CELL PLOIDY ALTERATIONS AND ABNORMAL EXPRESSION OF THE ALPHA-5-BETA-1 INTEGRIN
    AMADORI, M
    BERNERI, C
    ARCHETTI, IL
    [J]. VACCINE, 1994, 12 (02) : 159 - 166
  • [4] Phenotypic features of BHK-21 cells used for production of foot-and-mouth disease vaccine
    Amadori, M
    Volpe, G
    Defilippi, P
    Berneri, C
    [J]. BIOLOGICALS, 1997, 25 (01) : 65 - 73
  • [5] Cell recognition by foot-and-mouth disease virus that lacks the RGD integrin-binding motif: Flexibility in aphthovirus receptor usage
    Baranowski, E
    Ruiz-Jarabo, CM
    Sevilla, N
    Andreu, D
    Beck, E
    Domingo, E
    [J]. JOURNAL OF VIROLOGY, 2000, 74 (04) : 1641 - 1647
  • [6] Role of arginine-56 within the structural protein VP3 of foot-and-mouth disease virus (FMDV) O1 Campos in virus virulence
    Borca, Manuel V.
    Pacheco, Juan M.
    Holinka, Lauren G.
    Carrillo, Consuelo
    Hartwig, Ethan
    Garriga, Damia
    Kramer, Edward
    Rodriguez, Luis
    Piccone, Maria E.
    [J]. VIROLOGY, 2012, 422 (01) : 37 - 45
  • [7] THERMAL-STABILITY OF FOOT-AND-MOUTH-DISEASE VIRUS
    DOEL, TR
    BACCARINI, PJ
    [J]. ARCHIVES OF VIROLOGY, 1981, 70 (01) : 21 - 32
  • [8] Eko Hidayanto T.T., 2010, BERKALA FISIKA, V13, pA23
  • [9] Development of stable liquid formulations for adenovirus- based vaccines
    Evans, RK
    Nawrocki, DK
    Isopi, LA
    Williams, DM
    Casimiro, DR
    Chin, S
    Chen, MC
    Zhu, DM
    Shiver, JW
    Volkin, DB
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 2004, 93 (10) : 2458 - 2475